UBS AM’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding OBIO
UBS AM's OBIO Position: Q3 2026 in Review
UBS AM increased its Orchestra BioMed (OBIO) stake by 331% in Q3 2026, buying an estimated $10.2M and bringing the position to 2,765,467 shares worth $17.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1064.
UBS AM first reported a position in OBIO in Q2 2026 and has held it in 2 quarters since. 88 funds tracked by Wall St. Rank hold OBIO as of Q3 2026.
- UBS AM held 2,765,467 shares of Orchestra BioMed worth $17.2M as of Q3 2026.
- UBS AM bought 2,123,313 Orchestra BioMed shares in Q3 2026, an estimated $10.2M.
- Orchestra BioMed made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #1064 holding.
- UBS AM first reported a position in Orchestra BioMed in Q2 2026 and has held it in 2 quarters since.
- 88 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.